CELforPharma
Timeline
33 events since 2005Board
Filings
Financial
Establishments
20062008201020122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed PDFabbreviated format · 58 days before the deadline
2025
- General meeting, 06-06-2025
- Permanent representative, Luc De Langhe
- Permanent representative, Annelies Swaan
Annual accounts 2024 filed PDFabbreviated format · 49 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0871088704
2024
Back to profit net €37,590 The net result is €37,590, after one loss-making year.
Annual accounts 2023 filed PDFabbreviated format · 56 days before the deadline
2023
Weakest financial year net -€47,598 The net result drops to -€47,598, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2022 filed PDFabbreviated format · 53 days before the deadline
2022
Annual accounts 2021 filed PDFabbreviated format · 11 days before the deadline
New directorLAICO4Growth appointed, Luc De Langhe resigned · Permanent representative: DE LANGHE Luc · General meeting of 14-02-20227 points ▸
- General meeting, 14-02-2022
- Director resignation, Luc De Langhe (sole director (not named in the articles))
- Permanent representative, DE LANGHE Luc, mentioned twice in the deed
- Director appointment, LAICO4Growth (director (not named in the articles))
- 200 shares
- Registered office clause, Jan Emiel Mommaertslaan 20A, 1831 Diegem
- Power of attorney, Hugo VAN ELSLANDE
- The deed holds 5 more points.
2021
Highest result from 2006 to 2025 net €331,031 ▲1,806% The operating result of €469,590 and the net result of €331,031 are both a record.
Annual accounts 2020 filed PDFabbreviated format · 57 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 27 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 40 days before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 43 days before the deadline
2017
Annual accounts 2016 filed PDFabbreviated format · 53 days before the deadline
2016
Equity above €500,000 equity €501,218 ▲19.7% With a profit in every financial year since 2006, equity grows to €501,218.
Annual accounts 2015 filed PDFabbreviated format · 47 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 39 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 65 days before the deadline
2013
Equity above €200,000 equity €210,380 ▲15.3% With a profit in every financial year since 2006, equity grows to €210,380.
Annual accounts 2012 filed PDFabbreviated format · 26 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 36 days before the deadline
2011
Equity above €150,000 equity €179,262 ▲41.9% With a profit in every financial year since 2006, equity grows to €179,262.
Annual accounts 2010 filed PDFabbreviated format · 46 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 50 days before the deadline
2009
Equity above €100,000 equity €120,563 ▲29.3% With a profit in every financial year since 2006, equity grows to €120,563.
Annual accounts 2008 filed PDFabbreviated format · 64 days before the deadline
2008
Annual accounts 2007 filed PDFabbreviated format · 48 days before the deadline
2007
Annual accounts 2006 filed PDFabbreviated format · 26 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Incorporation PDFpublished on 19-01-2005
First establishment Jan Mommaertslaan 20a, Machelen (Brab.)
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank